Quick Search:       Advanced Search
Application progress of precision pharmacy in idiopathic membranous nephropathy
Received:April 15, 2020  Revised:May 13, 2020  Click here to download the full text
Citation of this paper:FU Ran,WANG Xiao-nan,DING Cong-yang,MENG Lu,DONG Zhan-jun.Application progress of precision pharmacy in idiopathic membranous nephropathy[J].Chinese Journal of Clinical Medicine,2021,28(2):305-309
Hits: 1030
Download times: 475
Author NameAffiliationE-mail
FU Ran Graduate School, Hebei Medical University, Shijiazhuang 050017, Hebei, China
Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, Hebei, China 
 
WANG Xiao-nan Graduate School, Hebei Medical University, Shijiazhuang 050017, Hebei, China
Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, Hebei, China 
 
DING Cong-yang Graduate School, Hebei Medical University, Shijiazhuang 050017, Hebei, China
Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, Hebei, China 
 
MENG Lu Graduate School, Hebei Medical University, Shijiazhuang 050017, Hebei, China  
DONG Zhan-jun Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, Hebei, China 13313213656@126.com 
Abstract:Idiopathic membranous nephropathy is a kind of autoimmune disease. Its duration is long and it is easy to develop into end-stage renal disease. The precision pharmacy abandons the traditional non-individualized medication method and can provide patients with accurate, safe, and economical individualized medication scheme. This paper summarizes some technical means which are based on the precision pharmacy, such as therapeutic drug monitoring, pharmacogenomics and population pharmacokinetics in the treatment of idiopathic membranous nephropathy to provide reference for clinical rational drug use.
keywords:precision pharmacy  idiopathic membranous nephropathy  therapeutic drug monitoring  pharmacogenomics  population pharmacokinetics
HTML  View Full Text  View/Add Comment  Download reader